A new study has brought a wave of hope: young women who received the HPV vaccine are experiencing dramatically lower rates of cervical cancer, and in vaccinated women aged 20–24, there have been no recorded deaths from cervical cancer.
For families, for young women, and for charities like ours, this isn’t just encouraging — it’s a sign that progress is happening. Prevention is working. Education is making a difference. And future generations are being better protected than ever before.
But it also raises an important question: What does this mean for the Faye Knowles‑Chapman Foundation and the work we do?
A Huge Step Forward — But Not the Full Journey
The HPV vaccine is one of the most powerful tools we have in preventing cervical cancer. This new study proves that. It shows that girls who receive the vaccine early — ideally before age 16 — are significantly less likely to develop cervical cancer later in life.
But it doesn’t mean cervical cancer has disappeared. It doesn’t mean all strains are covered. And it doesn’t mean screening is no longer needed.
Most importantly, it doesn’t change the fact that young women under 25 are still not offered cervical screening, even when they have symptoms or concerns.
The vaccine is a major step forward, but it doesn’t replace early investigation, listening to young women, or giving them access to screening when something feels wrong.
Why Our Work Still Matters
Even with the incredible success of the HPV vaccine, young women still need:
- Access to cervical screening before 25 when symptoms appear
- Healthcare professionals who take their concerns seriously
- Education about symptoms, risk factors, and their own bodies
- Support when they feel dismissed or unsure where to turn
The vaccine protects many — but not all. And it doesn’t help those who didn’t receive it early enough, or who still develop symptoms despite being vaccinated.
This is where our foundation continues to play a vital role.
Faye’s Story in a Changing Landscape
Faye was part of the generation who didn’t benefit from the HPV vaccine early enough. She didn’t have that layer of protection. She didn’t have access to screening when she needed it. And her symptoms were dismissed because of her age.
Her story is a heartbreaking reminder that prevention alone isn’t enough. Young women still need access. They still need reassurance. They still need to be taken seriously.
The new study gives us hope — but it also highlights exactly why the foundation exists. Faye didn’t get the chance she deserved, and her legacy drives us to make sure other young women do.
Hope for the Future, Action for Today
We celebrate this study. We welcome it. We’re grateful for the protection it gives to young girls growing up today. It shows that the fight against cervical cancer is moving in the right direction.
But our mission isn’t finished.
The HPV vaccine is helping protect the next generation. Our foundation is fighting for the ones who still fall through the gaps.
Together, we move closer to a future where no young woman feels unheard, dismissed, or left to face cervical cancer alone.